Search Results 2181-2190 of 40325 for Two-phase

1. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

3. A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity - Mayo Clinic

   Study phase4. Study IDs ... There are also less common very early (phase 0) and later (phase 4) phases. ... - Participants with MAS score of at least 2 at two ...

4. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers - Mayo Clinic

   To assess the safety and pharmacokinetics (PK) in order to determine a maximally tolerated dose (MTD) or recommended phase 2 dose (RP2D) of REGN4018 as ...

6. Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based Chemotherapy - Mayo Clinic

   The study has 2 parts, Phase 1a and Phase 1b. The goal of Phase 1a is to gather safety, PK and initial efficacy data for 225Ac-ABD147 to better understand best ...

7. MEmbranous Nephropathy Trial Of Rituximab - Mayo Clinic

   Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

8. Breast cancer - Doctors and departments - Mayo Clinic

   ... Stage 4 breast cancer, BRCA gene mutation ... Stage 4 breast cancer, BRCA ... Castro Garcia, M.D.. Pagination Doctor search. Go to page 11 · Go to page 22 ...

9. Lurbinectedin + Doxorubicin In Leiomyosarcoma - Mayo Clinic

   Creatine Phosphokinase (CPK) < 2.5 × institutional ULN on two different determinations performed one week (± 1 day) apart. ... phase 2 study. There is no limit on ...

10. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies - Mayo Clinic

    This is an open label, single arm phase 1 dose escalation study and phase 2 study of BBI608 in combination with paclitaxel in patients with advanced ...